PBAC rejects inhaler restrictions

The Pharmaceutical Benefits Advisory Committee has rejected moves to change PBS restrictions on fixed dose combination LABA/ICS inhalers for children to “authority streamlined”. In a response to the Department of Health’s review of PBS Medicines Used to Treat Asthma in Children the PBAC said that while it accepted the findings of the review that there was ...

Already a member?

Login to keep reading.

© 2021 the limbic